Q: Hi folks,almost to embaressed to admit still own some Concordia,but company issued n/r:Concordia International Corp. Makes Final Earn Out Payment to Cinven,Today's payment of £72 million, plus interest of approximately £1.5 million, was paid with cash on hand.But a poster stated,"Had to raise 9.5% 1st lien bonds to pay the earn out. Hardly a good sign.". Could I please get your opinion on todays news and future of company going forward, at least Trump yesterday seemed to throw an olive branch at pharma companies that he would work with them and not bury them. Thanks as always, jb
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: made another repayment to cinven today from cash on hand. any comments please.
Q: Could I get your thoughts on Centric Health Corp. It is a small healthcare company and has had a big run up recently, I was thinking of initiating a 1/2 position. Thanks.
Q: Trillium continues to drop even after the end of tax-loss season. I'm second guessing that this has long term potential - I thought the explanation of the effacy vs. toxicity profile was good last month and expected the stock to be stronger. What are your thoughts?
Q: I wonder if you would provide me with your analysis of PHM's year end financials released today. Thanks.
Francesco
Francesco
Q: What's the outlook for this company in the next two years? Thanks.
Q: Do you have an opinion on this ETF? It has a yield of 8.8%, utilizing a coverd call strategy.
Q: Now that PLI has received orphan drug designation for PBI-4050, what is the liklihood the stock will rise to $4.75 as predicted? If it does reach that level, is that a take-off point to much higher levels?
Elmer
Elmer
Q: Hi Peter, What is your analysis of Valeant? I went through the conference call and recent presentation and it sounds they are on track to pay down $5B in next 12 months. Is market panicking?
Q: Hi Peter! SIS said in their statement "There are over a thousand resellers of accessibility products in North America." Their purpose behind this statement was to iterate that there are many opportunities for acquisitions that could improve synergies, but I'm more concerned about how they maintain a competitive advantage. Do they depend too much on R&D? If not, what makes them stand out from the rest and what are the barriers to entry? Is there any brand loyalty among its customers? Do you see them being bought out in the future (i.e. like United Technologies that own OTIS elevators)? Thanks!
Q: Any idea why BMY tanked, down 11% Friday?
Thanks for your ongoing efforts toward your subscribers.
Mark
Thanks for your ongoing efforts toward your subscribers.
Mark
Q: VBI Vaccines
Could you please give your opinion on this stock, and does it merit a buy at this price.
Could you please give your opinion on this stock, and does it merit a buy at this price.
Q: Any insights into this company and their expected success with their new anti-clotting drug?
-
Liminal BioSciences Inc. (LMNL)
-
Knight Therapeutics Inc. (GUD $6.45)
-
Merus Labs International Inc. (MSL $1.65)
Q: I read your summary back in December on MSL. It was not flattering. As you expected the stock continues to languish. Are there other Companies in this space you would prefer and would you sell MSL (small holding) to buy it?
Q: Hi Peter and Team,
I own this stock and am 20% under water, it continues going down but I could not find the reason. This stock looks cheap, the company have 17 m cash and no debt.
Pls give your thought on this company.
Should I continue to hold it?
Thank you for your professional advice.
Pui
I own this stock and am 20% under water, it continues going down but I could not find the reason. This stock looks cheap, the company have 17 m cash and no debt.
Pls give your thought on this company.
Should I continue to hold it?
Thank you for your professional advice.
Pui
Q: Would you give me your latest thoughts on TEVA
Q: MPH took a big dive today. Do you know why and is there some concern here? I am up over 100% so not too worried but would like some info.
Q: I have no exposure to healthcare but I would like to have some exposure. Can you recommend some investments to this sector and it does not have to be Canadian companies?
Q: Can you give me the updated short position on PLI please?
Joel
Joel
Q: I am underweight Healthcare, but do own RX - GILD - GUD - SIA. Both RX and GILD are down double digits. GILD I gather from previous questions is probably worth holding on to. But what about RX ...buy more, sell or hold? If sell, what would your "buy" suggestions be to beef up my healthcare weighting?
Thanks again.
Thanks again.